US Stock MarketDetailed Quotes

KYTX Kyverna Therapeutics

Watchlist
  • 13.230
  • +0.230+1.77%
Close May 28 16:00 ET
  • 13.230
  • 0.0000.00%
Post 16:00 ET
570.41MMarket Cap-7512P/E (TTM)

Kyverna Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Cash, cash equivalents and short term investments
--369.79M
12.12%57.54M
12.12%57.54M
--77.27M
-32.53%51.32M
--51.32M
--76.07M
-Cash and cash equivalents
--224.29M
-8.18%34.65M
-8.18%34.65M
--22.97M
-50.39%37.74M
--37.74M
--76.07M
-Short-term investments
--145.51M
68.51%22.9M
68.51%22.9M
--54.31M
--13.59M
--13.59M
--0
Other current assets
--5.69M
61.79%3.12M
61.79%3.12M
--2.14M
89.12%1.93M
--1.93M
--1.02M
Total current assets
--375.49M
13.92%60.66M
13.92%60.66M
--79.41M
-30.92%53.25M
--53.25M
--77.09M
Non current assets
Net PPE
--12.75M
-14.72%10.61M
-14.72%10.61M
--11.07M
59.34%12.44M
--12.44M
--7.81M
-Gross PPE
--15.48M
-6.84%13.1M
-6.84%13.1M
--13.33M
62.53%14.06M
--14.06M
--8.65M
-Accumulated depreciation
---2.73M
-53.77%-2.49M
-53.77%-2.49M
---2.26M
-92.16%-1.62M
---1.62M
---842K
Other non current assets
--1.74M
218.26%3.92M
218.26%3.92M
--2.01M
107.76%1.23M
--1.23M
--593K
Total non current assets
--14.5M
6.28%14.53M
6.28%14.53M
--13.08M
62.75%13.67M
--13.67M
--8.4M
Total assets
--389.98M
12.36%75.2M
12.36%75.2M
--92.49M
-21.72%66.92M
--66.92M
--85.49M
Liabilities
Current liabilities
Payables
--7.45M
200.34%4.36M
200.34%4.36M
--3.02M
87.71%1.45M
--1.45M
--773K
-accounts payable
--7.45M
200.34%4.36M
200.34%4.36M
--3.02M
87.71%1.45M
--1.45M
--773K
Current accrued expenses
--9.33M
0.00%6.25M
0.00%6.25M
--6.25M
-5.66%6.25M
--6.25M
--6.63M
Current debt and capital lease obligation
--3.72M
28.24%2.92M
28.24%2.92M
--2.8M
179.73%2.28M
--2.28M
--814K
-Current capital lease obligation
--3.72M
28.24%2.92M
28.24%2.92M
--2.8M
179.73%2.28M
--2.28M
--814K
Current deferred liabilities
----
----
----
----
----
----
--6M
Other current liabilities
----
522.83%3.52M
522.83%3.52M
--2.95M
-1.74%565K
--565K
--575K
Current liabilities
--21.87M
66.13%19.86M
66.13%19.86M
--16.87M
-24.95%11.95M
--11.95M
--15.93M
Non current liabilities
Long term debt and capital lease obligation
--7.13M
-25.68%6.16M
-25.68%6.16M
--6.84M
74.79%8.29M
--8.29M
--4.74M
-Long term capital lease obligation
--7.13M
-25.68%6.16M
-25.68%6.16M
--6.84M
74.79%8.29M
--8.29M
--4.74M
Non current deferred liabilities
----
----
----
----
----
----
--1.03M
Non current accrued expenses
----
----
----
----
----
----
--1.25M
Preferred securities outside stock equity
--0
49.64%180.57M
49.64%180.57M
--180.57M
11.00%120.67M
--120.67M
--108.72M
Other non current liabilities
----
----
----
----
-92.31%6K
--6K
--78K
Total non current liabilities
--7.13M
44.79%186.73M
44.79%186.73M
--187.42M
11.36%128.97M
--128.97M
--115.81M
Total liabilities
--28.99M
46.60%206.59M
46.60%206.59M
--204.29M
6.97%140.92M
--140.92M
--131.74M
Shareholders'equity
Share capital
--0
--0
--0
--0
--0
--0
--0
-common stock
--0
--0
--0
--0
--0
--0
--0
Retained earnings
---162.74M
-79.77%-136.04M
-79.77%-136.04M
---115.38M
-61.76%-75.68M
---75.68M
---46.78M
Paid-in capital
--523.73M
172.10%4.64M
172.10%4.64M
--3.57M
221.89%1.71M
--1.71M
--530K
Gains losses not affecting retained earnings
---1K
115.38%4K
115.38%4K
--5K
---26K
---26K
--0
Total stockholders'equity
--360.99M
-77.57%-131.4M
-77.57%-131.4M
---111.81M
-59.98%-74M
---74M
---46.25M
Total equity
--360.99M
-77.57%-131.4M
-77.57%-131.4M
---111.81M
-59.98%-74M
---74M
---46.25M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Cash, cash equivalents and short term investments --369.79M12.12%57.54M12.12%57.54M--77.27M-32.53%51.32M--51.32M--76.07M
-Cash and cash equivalents --224.29M-8.18%34.65M-8.18%34.65M--22.97M-50.39%37.74M--37.74M--76.07M
-Short-term investments --145.51M68.51%22.9M68.51%22.9M--54.31M--13.59M--13.59M--0
Other current assets --5.69M61.79%3.12M61.79%3.12M--2.14M89.12%1.93M--1.93M--1.02M
Total current assets --375.49M13.92%60.66M13.92%60.66M--79.41M-30.92%53.25M--53.25M--77.09M
Non current assets
Net PPE --12.75M-14.72%10.61M-14.72%10.61M--11.07M59.34%12.44M--12.44M--7.81M
-Gross PPE --15.48M-6.84%13.1M-6.84%13.1M--13.33M62.53%14.06M--14.06M--8.65M
-Accumulated depreciation ---2.73M-53.77%-2.49M-53.77%-2.49M---2.26M-92.16%-1.62M---1.62M---842K
Other non current assets --1.74M218.26%3.92M218.26%3.92M--2.01M107.76%1.23M--1.23M--593K
Total non current assets --14.5M6.28%14.53M6.28%14.53M--13.08M62.75%13.67M--13.67M--8.4M
Total assets --389.98M12.36%75.2M12.36%75.2M--92.49M-21.72%66.92M--66.92M--85.49M
Liabilities
Current liabilities
Payables --7.45M200.34%4.36M200.34%4.36M--3.02M87.71%1.45M--1.45M--773K
-accounts payable --7.45M200.34%4.36M200.34%4.36M--3.02M87.71%1.45M--1.45M--773K
Current accrued expenses --9.33M0.00%6.25M0.00%6.25M--6.25M-5.66%6.25M--6.25M--6.63M
Current debt and capital lease obligation --3.72M28.24%2.92M28.24%2.92M--2.8M179.73%2.28M--2.28M--814K
-Current capital lease obligation --3.72M28.24%2.92M28.24%2.92M--2.8M179.73%2.28M--2.28M--814K
Current deferred liabilities --------------------------6M
Other current liabilities ----522.83%3.52M522.83%3.52M--2.95M-1.74%565K--565K--575K
Current liabilities --21.87M66.13%19.86M66.13%19.86M--16.87M-24.95%11.95M--11.95M--15.93M
Non current liabilities
Long term debt and capital lease obligation --7.13M-25.68%6.16M-25.68%6.16M--6.84M74.79%8.29M--8.29M--4.74M
-Long term capital lease obligation --7.13M-25.68%6.16M-25.68%6.16M--6.84M74.79%8.29M--8.29M--4.74M
Non current deferred liabilities --------------------------1.03M
Non current accrued expenses --------------------------1.25M
Preferred securities outside stock equity --049.64%180.57M49.64%180.57M--180.57M11.00%120.67M--120.67M--108.72M
Other non current liabilities -----------------92.31%6K--6K--78K
Total non current liabilities --7.13M44.79%186.73M44.79%186.73M--187.42M11.36%128.97M--128.97M--115.81M
Total liabilities --28.99M46.60%206.59M46.60%206.59M--204.29M6.97%140.92M--140.92M--131.74M
Shareholders'equity
Share capital --0--0--0--0--0--0--0
-common stock --0--0--0--0--0--0--0
Retained earnings ---162.74M-79.77%-136.04M-79.77%-136.04M---115.38M-61.76%-75.68M---75.68M---46.78M
Paid-in capital --523.73M172.10%4.64M172.10%4.64M--3.57M221.89%1.71M--1.71M--530K
Gains losses not affecting retained earnings ---1K115.38%4K115.38%4K--5K---26K---26K--0
Total stockholders'equity --360.99M-77.57%-131.4M-77.57%-131.4M---111.81M-59.98%-74M---74M---46.25M
Total equity --360.99M-77.57%-131.4M-77.57%-131.4M---111.81M-59.98%-74M---74M---46.25M
Currency Unit USDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion----Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Recent IPOs
Recent IPOs
Intraday+0.16%